HomeREGULATORY
REGULATORY

FPMAJ Chief Trades Barbs with Chuikyo Payer Rep, Says Western-Style HTA Doesn’t Fit Japan’s Unique Market Mechanism
(Oct.12.2017)

(from left) FPMAJ Chairman Masayo Tada, PhRMA Japan Executive Committee Chairman Patrik Jonsson, EFPIA Japan Director Heike Prinz at Chuikyo Meeting
The Japanese drug market is rigidly governed by its drug pricing system, and the market economy-oriented concept of western-style health technology assessments (HTAs) does not fit in such a controlled market, Masayo Tada, chairman of the Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ), maintained on October 11 ...
(LOG IN FOR FULL STORY)

News Calendar